Baseline lipid levels rather than the presence of reported body shape changes determine the degree of improvement in lipid levels after switching to atazanavir.

Translated title of the contribution: Baseline lipid levels rather than the presence of reported body shape changes determine the degree of improvement in lipid levels after switching to atazanavir.

M.G. van Vonderen, L. Gras, F. Wit, K. Brinkman, M.E. van der Ende, I.M. Hoepelman, F. de Wolf, P. Reiss

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionBaseline lipid levels rather than the presence of reported body shape changes determine the degree of improvement in lipid levels after switching to atazanavir.
Original languageUndefined/Unknown
Pages (from-to)168-180
Number of pages13
JournalHIV Clinical Trials
Volume10
Issue number3
Publication statusPublished - 2009

Cite this